Glenn Haifer

Part of Healius Ltd., Agilex Biolabs Pty Ltd. is a bioanalytical and toxicology laboratory based in Thebarton, Australia. The Australian company has been in the industry for 25 years and is known for delivering bioanalytical services for nonclinical and clinical trials with international research standards. Agilex has accelerated hundreds of trials worldwide with reliable and defendable toxicology studies, clinical bioanalysis, and biomarker data to improve human health. Jason Valentine has been the CEO of the company since 2019. Agilex Biolabs was acquired by Healius Ltd. on February 01, 2022 for $216.62 million.

Part of Healius Ltd., Agilex Biolabs Pty Ltd. is a bioanalytical and toxicology laboratory based in Thebarton, Australia. The Australian company has been in the industry for 25 years and is known for delivering bioanalytical services for nonclinical and clinical trials with international research standards. Agilex has accelerated hundreds of trials worldwide with reliable and defendable toxicology studies, clinical bioanalysis, and biomarker data to improve human health. Jason Valentine has been the CEO of the company since 2019. Agilex Biolabs was acquired by Healius Ltd. on February 01, 2022 for $216.62 million.

Part of Healius Ltd., Agilex Biolabs Pty Ltd. is a bioanalytical and toxicology laboratory based in Thebarton, Australia. The Australian company has been in the industry for 25 years and is known for delivering bioanalytical services for nonclinical and clinical trials with international research standards. Agilex has accelerated hundreds of trials worldwide with reliable and defendable toxicology studies, clinical bioanalysis, and biomarker data to improve human health. Jason Valentine has been the CEO of the company since 2019. Agilex Biolabs was acquired by Healius Ltd. on February 01, 2022 for $216.62 million.

Part of Healius Ltd., Agilex Biolabs Pty Ltd. is a bioanalytical and toxicology laboratory based in Thebarton, Australia. The Australian company has been in the industry for 25 years and is known for delivering bioanalytical services for nonclinical and clinical trials with international research standards. Agilex has accelerated hundreds of trials worldwide with reliable and defendable toxicology studies, clinical bioanalysis, and biomarker data to improve human health. Jason Valentine has been the CEO of the company since 2019. Agilex Biolabs was acquired by Healius Ltd. on February 01, 2022 for $216.62 million.